sur NANOBIOTIX (EPA:NANO)
NANOBIOTIX Enhances Supervisory Board with Two Key Additions
NANOBIOTIX has announced the appointment of Dr. Margaret A. Liu and Ms. Anat Naschitz to its Supervisory Board. These nominations aim to bolster the company's capacity for sustainable long-term growth.
Dr. Liu, a global expert in vaccines, gene therapy, and cancer immunotherapy, serves as CEO of PAX Therapeutics. Her extensive experience in academia, pharmaceuticals, and biotechnology is expected to be instrumental for NANOBIOTIX.
Ms. Naschitz, a seasoned life science investor and entrepreneur, is the co-founder of OrbiMed Israel. She brings a wealth of knowledge in capital utilization and biopharma investment, crucial for supporting the company's innovation strategies.
Laurent Levy, CEO and Chairman of NANOBIOTIX, stated that these new board members would be pivotal in advancing the company's nanophysics-based therapies for cancer treatment.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NANOBIOTIX